RECURSION PHARMACEUTICALS IN
Review SEC Form 13F institutional ownership, reported holding value and quarterly holder changes for RECURSION PHARMACEUTICALS IN CL A, CUSIP 75629v104.
Review SEC Form 13F institutional ownership, reported holding value and quarterly holder changes for RECURSION PHARMACEUTICALS IN CL A, CUSIP 75629v104.